BioLife Solutions, Inc. Income Statement
BLFS / Health Care|15 years of annual SEC 10-K data (FY2011-FY2025)
Line items include revenue, cost of goods sold, gross profit, operating expenses, interest, taxes, and net income with per-share data across 15 fiscal years. All figures from audited SEC 10-K filings.
Revenue has grown at a 26.0% compound annual rate over the past 6 years.
Based on SEC 10-K filings.
Key Data Points
- Altman Z-Score 4.67 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - | - | - | $11.0M | $8.2M | $6.4M | $6.2M | $8.9M | $5.7M | $2.8M |
| Cost of Revenue | $34.1M | $24.6M | $26.7M | - | - | - | $1.6M | $2.9M | $4.3M | $3.4M | $2.6M | $3.2M | $5.2M | $3.4M | $1.4M |
| Gross Profit | $62.1M | $50.1M | $41.3M | - | - | - | - | $13.5M | $6.7M | $4.8M | $3.8M | $3.0M | $3.8M | $2.3M | $1.4M |
| SG&A Expense | $45.5M | $40.6M | $42.8M | $33.3M | $33.7M | $15.3M | $8.9M | $2.7M | $4.5M | $4.6M | $4.9M | $4.0M | $2.7M | $2.2M | $1.8M |
| R&D Expense | $7.6M | $4.8M | $5.5M | $8.7M | $11.8M | $6.7M | $3.2M | $671.0K | $1.2M | $2.0M | $1.4M | $871.1K | $487.8K | $463.6K | $516.5K |
| Operating Income | -$16.6M | -$4.5M | -$17.2M | -$5.9M | -$35.2M | -$6.2M | -$220.0K | $1.4M | -$1.1M | -$4.9M | -$5.0M | -$3.1M | -$285.4K | -$942.2K | -$1.2M |
| Interest Expense | - | - | - | - | - | - | $5.0K | $5.0K | $190.0K | $100.0K | $0 | $177.3K | $742.2K | $733.4K | $671.0K |
| Income Tax | $49.0K | -$38.0K | -$64.0K | -$5.2M | -$20.1M | -$3.3M | -$1.5M | - | $0 | $0 | $0 | $0 | $0 | $0 | - |
| Net Income | -$4.6M | -$20.2M | -$68.0M | -$139.8M | -$8.9M | $2.0M | -$1.7M | $4.9M | -$2.5M | -$6.9M | -$4.2M | -$3.2M | -$1.1M | -$1.7M | -$2.0M |
| EPS (Basic) | -$0.09 | -$0.44 | -$1.55 | -$3.29 | -$0.23 | $0.07 | -$0.09 | -$1.48 | - | - | - | - | - | - | - |
| EPS (Diluted) | -$0.10 | -$0.44 | -$1.55 | -$3.25 | -$0.23 | -$0.06 | -$0.09 | -$1.48 | -$0.54 | -$0.35 | -$0.31 | -$0.22 | -$0.33 | -$0.03 | -$0.03 |
| Shares Outstanding | 48.6M | 46.1M | 43.7M | 43.1M | 38.5M | 27.3M | 19.5M | 14.6M | 12.9M | 12.4M | 12.1M | 5.0M | 5.0M | 69.7M | 69.7M |
| Gross Margin | - | - | - | - | - | - | - | - | 61.2% | 58.1% | 59.2% | 49.0% | 42.0% | 40.5% | 50.9% |
| Operating Margin | - | - | - | - | - | - | - | - | -9.6% | -59.0% | -77.8% | -50.6% | -3.2% | -16.6% | -43.9% |
| Profit Margin | - | - | - | - | - | - | - | - | -22.8% | -83.6% | -65.3% | -52.0% | -12.1% | -29.3% | -70.9% |